Annual Drug Patent Expirations for TOBI+PODHALER
Tobi Podhaler is a drug marketed by Mylan Speciality Lp and is included in one NDA. It is available from one supplier. There are ten patents protecting this drug.
Drug patent litigation for TOBI PODHALER.
This drug has sixty-five patent family members in twenty-eight countries.
The generic ingredient in TOBI PODHALER is tobramycin. One supplier is listed for this compound. Additional details are available on the tobramycin profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
